secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001193125-24-104871
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Gwen Melincoff not to stand for re-election at 2024 annual meeting
---------------------------------------------------------------------------

- Melincoff notified Board on April 17, 2024 that she will not seek re-election at the 2024 AGM.
- Decision not due to any disagreement with Soleno Therapeutics or its Board.
- Melincoff will continue as director until the 2024 Annual Meeting of Stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524104871/0001193125-24-104871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524104871/d818557d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-104871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer